Tinzaparin vs Warfarin for Acute Venous Thromboembolism

被引：1
|
作者：
Maruyama, Anna [1 ]
Tejani, Aaron M. [2 ]
Perry, Thomas L. [2 ]
机构：
[1] Univ British Columbia, Dept Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Therapeut Initiat, Vancouver, BC V6T 1Z3, Canada
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2016年 / 315卷 / 02期
关键词：
D O I：
10.1001/jama.2015.15067
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [1] Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer A Randomized Clinical Trial
    Lee, Agnes Y. Y.
    Kamphuisen, Pieter W.
    Meyer, Guy
    Bauersachs, Rupert
    Janas, Mette S.
    Jarner, Mikala F.
    Khorana, Alok A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (07): : 677 - 686
  • [2] Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial (vol 314, pg 677, 2015)
    Lee, A. Y.
    Kamphuisen, P. W.
    Meyer, G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (20): : 2048 - 2048
  • [3] CATCH: A randomized trial comparing tinzaparin versus warfarin for treatment of acute venous thromboembolism (VTE) in cancer patients
    Lee, Agnes Y.
    Bauersachs, Rupert
    Janas, Mette S.
    Jarner, Mikala F.
    Kamphuisen, Pieter W.
    Meyer, Guy
    Paz-Ares, Luis
    Khorana, Alok A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Tinzaparin in the treatment of venous thromboembolism
    Pineo, GF
    Hull, RD
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (12) : 2355 - 2362
  • [5] CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients
    Lee, Agnes Y. Y.
    Bauersachs, Rupert
    Janas, Mette S.
    Jarner, Mikala F.
    Kamphuisen, Pieter W.
    Meyer, Guy
    Khorana, Alok A.
    BMC CANCER, 2013, 13
  • [6] Treatment of venous thromboembolism with tinzaparin in oncological patients
    Ageno, Walter
    Barn, Sandro
    Di Nisio, Marcello
    Falanga, Anna
    Imberti, Davide
    Labianca, Roberto F.
    Mantovani, Lorenzo
    MINERVA MEDICA, 2019, 110 (03) : 251 - 258
  • [7] CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients
    Agnes YY Lee
    Rupert Bauersachs
    Mette S Janas
    Mikala F Jarner
    Pieter W Kamphuisen
    Guy Meyer
    Alok A Khorana
    BMC Cancer, 13
  • [8] Influence of cancer on the efficacy and safety of dabigatran vs. warfarin for the acute and extended treatment of venous thromboembolism
    Schulman, S.
    Eriksson, H.
    Goldhaber, S. Z.
    Kakkar, A.
    Kearon, C.
    Schellong, S.
    Feuring, M.
    Friedman, J.
    Kreuzer, J.
    THROMBOSIS RESEARCH, 2014, 133 : S221 - S221
  • [9] Dabigatran vs. warfarin in venous thromboembolism: a meta-analysis
    Sipahi, I.
    Cuhadaroglu, C.
    EUROPEAN HEART JOURNAL, 2015, 36 : 308 - 308
  • [10] Dabigatran or warfarin in the treatment of acute venous thromboembolism in antiphospholipid syndrome
    Schulman, S.
    Goldhaber, S.
    Kearon, C.
    Kakkar, A. K.
    Schellong, S.
    Eriksson, H.
    Schueler, E.
    Feuring, M.
    Kreutzer, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 985 - 985
12345